Suppression of cancer

Details for Australian Patent Application No. 2009315435 (hide)

Owner Syntaxin Limited

Inventors Madec, Frederic; Lecane, Philip; Marks, Philip; Foster, Keith

Agent Freehills

Pub. Number AU-A-2009315435

PCT Pub. Number WO2010/055358

Priority 0820970.2 17.11.08 GB

Filing date 17 November 2009

Wipo publication date 20 May 2010

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

C12N 9/52 (2006.01) Enzymes, e.g. ligases (6.) - derived from bacteria

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/055358 Priority application(s): WO2010/055358

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009315441-Novel composition based on gammahydroxybutyric acid

2009315429-Assessment of gait